Stock Analysis

MTU Aero Engines And Two More Value Stocks On The German Exchange For Your Consideration

XTRA:RDC
Source: Shutterstock

Amidst a landscape of modest gains across major European stock indices, with Germany's DAX index recently climbing by 1.32%, investors are keenly watching for opportunities that might defy broader market trends. In such a context, identifying undervalued stocks becomes particularly compelling, offering potential for significant value in a market ripe with cautious optimism.

Top 10 Undervalued Stocks Based On Cash Flows In Germany

NameCurrent PriceFair Value (Est)Discount (Est)
Stabilus (XTRA:STM)€45.75€81.2243.7%
technotrans (XTRA:TTR1)€18.55€29.7737.7%
Novem Group (XTRA:NVM)€5.20€10.1949%
PSI Software (XTRA:PSAN)€22.80€43.4947.6%
Stratec (XTRA:SBS)€46.45€82.4243.6%
SBF (DB:CY1K)€3.42€5.8341.3%
CHAPTERS Group (XTRA:CHG)€24.00€46.6348.5%
MTU Aero Engines (XTRA:MTX)€252.80€421.3440%
Your Family Entertainment (DB:RTV)€2.46€4.5145.5%
Redcare Pharmacy (XTRA:RDC)€134.60€215.3637.5%

Click here to see the full list of 29 stocks from our Undervalued German Stocks Based On Cash Flows screener.

Here's a peek at a few of the choices from the screener

MTU Aero Engines (XTRA:MTX)

Overview: MTU Aero Engines AG operates in the design, production, marketing, and maintenance of commercial and military aircraft engines and industrial gas turbines globally, with a market capitalization of approximately €13.61 billion.

Operations: MTU Aero Engines generates revenue primarily through two segments: the Commercial Maintenance Business (MRO), which brought in €4.35 billion, and the Commercial and Military Engine Business (OEM), which accounted for €1.27 billion.

Estimated Discount To Fair Value: 40%

MTU Aero Engines AG, trading significantly below its estimated fair value, presents an intriguing case for investors focused on cash flow-based valuations. Despite a slight decline in net income and EPS as reported in Q1 2024, the company is poised for substantial growth with earnings expected to increase by 35.51% annually. Additionally, MTU's revenue growth forecast at 12.2% yearly outpaces the German market's average, supporting its classification as undervalued based on discounted cash flows.

XTRA:MTX Discounted Cash Flow as at Jul 2024
XTRA:MTX Discounted Cash Flow as at Jul 2024

Redcare Pharmacy (XTRA:RDC)

Overview: Redcare Pharmacy NV is an online pharmacy operating across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of approximately €2.74 billion.

Operations: The company generates revenue primarily through its DACH segment, which brought in €1.62 billion, and its International operations, contributing €369.34 million.

Estimated Discount To Fair Value: 37.5%

Redcare Pharmacy, with a current trading price of €134.6 against a fair value estimate of €215.36, underscores its undervalued status in the German market based on cash flows. Despite experiencing significant share price volatility recently, the company reported a substantial increase in sales to €560.22 million from €372.05 million year-over-year as of Q1 2024 and reduced its net loss to €7.81 million from €10.22 million. Forecasted revenue growth at 17.1% annually surpasses the German market's 5.2%, coupled with an anticipated shift to profitability within three years and earnings growth projected at 47.38% per year, although concerns about shareholder dilution and low expected return on equity (7.5%) temper its outlook.

XTRA:RDC Discounted Cash Flow as at Jul 2024
XTRA:RDC Discounted Cash Flow as at Jul 2024

Kontron (XTRA:SANT)

Overview: Kontron AG specializes in providing Internet of Things (IoT) solutions both in Austria and globally, with a market capitalization of approximately €1.24 billion.

Operations: Kontron AG's revenue is primarily generated from three segments: Europe (€971.03 million), Global (€269.17 million), and Software + Solutions (€306.81 million).

Estimated Discount To Fair Value: 34.3%

Kontron AG, priced at €20.08, stands below the calculated fair value of €30.55, suggesting undervaluation based on cash flows. Despite this, its revenue growth forecast at 13.2% annually is modest compared to sector giants but still outpaces the broader German market's 5.2%. Recent product launches like the VX6096 highlight its innovative edge and potential market expansion. However, a low forecasted return on equity of 17.2% in three years and an unstable dividend track underscore financial cautionary notes amidst its growth narrative.

XTRA:SANT Discounted Cash Flow as at Jul 2024
XTRA:SANT Discounted Cash Flow as at Jul 2024

Turning Ideas Into Actions

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com